Great Hair
Natural health product licensed in Canada
- Licence holder
- Atma Nutrition
- NPN or DIN-HM
- 80076626
- Status
- Active licence
- Licence date
- 10 April 2017
- Revision date
- 24 August 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 250 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 100 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 100 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Serenoa repens Source : Fruit | 125 mg | Not calculated |
| Cuivre Source : Gluconate de cuivre (II) | 0.5 mg | 1,000 µg |
| Folate Source : Acide folique | 200 mcg | Not calculated |
| Biotine Source : Biotine | 250 mcg | 500 µg |
| Calcium Source : Carbonate de calcium | 100 mg | 200,000 µg |
| Riboflavine Source : Riboflavine | 50 mg | 100,000 µg |
| Ginkgo biloba Source : Feuille Potency : 24 % Flavonoid glycosides | 15 mg | Not calculated |
| Vitamine A Source : Acétate de vitamine A | 1,500 mcg EAR | Not calculated |
| Vitamine C Source : Acide ascorbique | 125 mg | 250,000 µg |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 8 mg AT | Not calculated |
| Thiamine Source : Thiamine | 15 mg | 30,000 µg |
| Niacinamide Source : Niacinamide | 15 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxal | 50 mg | 100,000 µg |
| Zinc Source : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH) | 2.5 mg | 5,000 µg |
| Choline Source : Bitartrate de choline | 125 mg | Not calculated |
| Silicium Source : Dioxyde de silicium | 20 mg | Not calculated |
| Inositol Source : Inositol | 125 mg | Not calculated |
| L-cystéine Source : L-cystéine | 50 mcg | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 25 mg | Not calculated |
| Prunus africana Source : Écorce âgée | 50 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 500 mg Potency : 10 mg Catechins | 25 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 5 mg Caffeine | Not specified | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 250 mg Potency : 80 % Oligomeric proanthocyanidins | 12.5 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Stéarate de magnésium, Cellulose microcristalline, Acide stéarique, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to maintain healthy hair, nails and skin. Helps in tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient. Some people may experience mild gastrointestinal bloating, constipation or indigestion. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally).
Source
Official Health Canada record, licence 80076626
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging